Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bio Key International Inc

NASDAQ: BKYI · Technology · 6 alerts · CIK 1019034

Share price
$2.09Close, Nov 16
Market cap
$4.25M
Shares outstanding
2.04MLatest SEC cover page
Sector
Technology
Industry
Services-Prepackaged SoftwareSIC 7372

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bio Key International Inc filings on SEC EDGAR ↗

3:57 PM ET 10-Q
Financial Results ▶ Call

Bio Key International Q3 2026 Results: Net Loss of $886K, Loss Narrows

BIO-key International reported total revenues of $5.5M for the nine months ended September 30, 2026, an increase from $4.9M in the prior year period, driven by higher license fees. Despite the revenue growth, the company incurred a net loss available to common stockholders of $6.2M, significantly impacted by a $4.5M deemed dividend related to a warrant inducement.

Key figure
Net loss $886K
8:31 AM ET 8-K
Financial Results

Bio Key International Financial Results

BIO-key International reported Q3 2026 financial results, highlighted by a 39% increase in software license fee revenue to $1.3 million and a gross margin improvement to 90%. The company narrowed its quarterly net loss to $0.89 million and retired its remaining outstanding debt, leaving the firm effectively debt-free.

Term
Q3 2026

“Our Q3’26 results reflect the building strength of our core software business. Software license fee revenue grew 39% in Q3’26, offsetting variability in our more episodic hardware and services revenue and lifting gross margin to 90% from 77% a year ago.”

Mike DePasquale, CEO

“Year to date we have grown revenue by 14%, reduced our net loss by 42% and we retired our remaining note outstanding leaving us effectively debt free.”

Mike DePasquale, CEO
5:07 PM ET 8-K
Shareholder Meeting

Bio Key International Shareholder Meeting

BIO-key International reported the final voting results from its 2026 Annual Meeting of Stockholders, which concluded on October 30, 2026. Stockholders approved Proposal 4, authorizing the issuance of up to 1,236,668 shares of common stock upon the exercise of warrants from an August 2026 inducement transaction to comply with Nasdaq Listing Rule 5635(d).

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.